Agarigen, Incorporated Contract Details

Defense contract under the Defense Advanced Research Projects Agency awarded to Agarigen, Incorporated on 9/19/2008.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: Agarigen, Incorporated
Department: Defense Advanced Research Projects Agency
Awarded: 9/19/2008

Agarigen Inc.*, Durham, N.C., is being awarded a $9,360,477 modification to a previously awarded other transaction for prototypes agreement for phase II of the Accelerated Manufacture of Pharmaceuticals program. Work will be performed in Durham, N.C., (96 percent), Coatsville, Pa., (1 percent), University Park, Pa., (3 percent), and is expected to be completed Dec. 2010. Funds will expire at the end of the current fiscal year. This is a follow on to a competitive award based on a solicitation issued in Federal Business Opportunities on May 11, 2006, for which over 10 proposals were received. The contracting activity is the Defense Advanced Research Projects Agency, Arlington, Va., (HR0011-07-9-0004, P00006).

Total Contract Value: $9,360,477

View all contracts that include "Agarigen, Incorporated" in the MiC database.